ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 51

$618K Total Retail Price of All Prescriptions

Rank: 15 out of 51

329 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

26% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 27%.

Risky Drugs to Seniors

3% of this provider’s 8,393 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 579 399 1 5
SIMVASTATIN 537 429 2 4
OMEPRAZOLE 447 327 3 3
HYDROCODONE-ACETAMINOPHEN 378 202 S3 4 1
LISINOPRIL 371 262 5 7
METFORMIN HCL 323 234 6 9
LOSARTAN-HYDROCHLOROTHIAZIDE 281 206 7 66
ATORVASTATIN CALCIUM 263 171 8 30
FUROSEMIDE 248 197 9 2
LEVOTHYROXINE SODIUM 247 181 10 6
HYDROCHLOROTHIAZIDE 221 147 11 15
CARVEDILOL 179 137 12 13
DONEPEZIL HCL 165 153 13 17
NAMENDA 165 165 13 16
POTASSIUM CHLORIDE 161 130 15 8
CIPROFLOXACIN HCL 156 107 16 48
MELOXICAM 150 99 17 20
WARFARIN SODIUM 140 64 18 11
LANTUS 137 77 19 31
LOSARTAN POTASSIUM 135 84 20 29
METOPROLOL TARTRATE 127 108 21 14
PANTOPRAZOLE SODIUM 116 71 22 34
CRESTOR 114 59 23 46
CYCLOBENZAPRINE HCL 110 38 R 24 53
EXELON 110 110 24 50
HYDRALAZINE HCL 108 69 26 52
ESCITALOPRAM OXALATE 105 78 27 39
GLIPIZIDE ER 102 79 28 122
FLUTICASONE PROPIONATE 98 70 29 51
MEGESTROL ACETATE 92 75 R 30 88
HUMULIN R 88 69 31 112
ALLOPURINOL 88 83 31 43
DIGOXIN 85 85 33 42
TRAMADOL HCL 85 41 33 10
KLOR-CON M20 82 71 35 83
PRAVASTATIN SODIUM 81 57 36 19
CLONIDINE HCL 80 68 37 26
MIRTAZAPINE 80 54 37 21
IBUPROFEN 79 45 39 93
GLIPIZIDE 78 49 40 40
METOPROLOL SUCCINATE 78 51 40 25
CITALOPRAM HBR 76 57 42 18
ZOLPIDEM TARTRATE 72 52 43 22
SYNTHROID 71 62 44 200
CLOPIDOGREL 68 39 45 41
ISOSORBIDE MONONITRATE ER 66 31 46 57
GABAPENTIN 64 33 47 12
LEVEMIR 63 58 48 111
NOVOLIN R 63 45 48 78
DIVALPROEX SODIUM 62 47 50 44
TAMSULOSIN HCL 61 48 51 36
ATENOLOL 60 56 52 33
NEXIUM 59 26 53 24
RISPERIDONE 57 45 54 27
ZETIA 57 25 54 153
FAMOTIDINE 56 51 56 55
ADVAIR DISKUS 54 28 57 72
LEVETIRACETAM 52 29 58 61
RAMIPRIL 51 31 59 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.